Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lee Walmsley

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Cellular and Molecular Medicine|October 28, 2021
Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastomaAndrew J Massey, Karen Benwell, Mike Burbridge, et al.
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Cellular and Molecular Medicine|October 28, 2021
Targeting DYRK1A/B kinases to modulate p21-cyclin D1-p27 signalling and induce anti-tumour activity in a model of human glioblastomaAndrew J Massey, Karen Benwell, Mike Burbridge, et al.
Journal of Medicinal Chemistry|June 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1BDavid Lee Walmsley, James B Murray, Pawel Dokurno, et al.
Journal of Medicinal Chemistry|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A InhibitorsCsaba Weber, Melinda Sipos, Attila Paczal, et al.
Journal of Medicinal Chemistry|November 19, 2020
Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial ActivityYousuke Yamada, Hajime Takashima, David Lee Walmsley, et al.
Pageof 1